Subir material

Suba sus trabajos a SEDICI, para mejorar notoriamente su visibilidad e impacto

 

Mostrar el registro sencillo del ítem

dc.date.accessioned 2014-07-04T18:02:30Z
dc.date.available 2014-07-04T18:02:30Z
dc.date.issued 2006-05
dc.identifier.uri http://sedici.unlp.edu.ar/handle/10915/37573
dc.description.abstract The sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA2a) is under the control of an SR protein named phospholamban (PLN). Dephosphorylated PLN inhibits SERCA2a, whereas phosphorylation of PLN at either the Ser16 site by PKA or the Thr17 site by CaMKII reverses this inhibition, thus increasing SERCA2a activity and the rate of Ca2+ uptake by the SR. This leads to an increase in the velocity of relaxation, SR Ca2+ load and myocardial contractility. In the intact heart, β-adrenoceptor stimulation results in phosphorylation of PLN at both Ser16 and Thr17 residues. Phosphorylation of the Thr17 residue requires both stimulation of the CaMKII signaling pathways and inhibition of PP1, the major phosphatase that dephosphorylates PLN. These two prerequisites appear to be fulfilled by β-adrenoceptor stimulation, which as a result of PKA activation, triggers the activation of CaMKII by increasing intracellular Ca2+, and inhibits PP1. Several pathological situations such as ischemia-reperfusion injury or hypercapnic acidosis provide the required conditions for the phosphorylation of the Thr17 residue of PLN, independently of the increase in PKA activity, i.e., increased intracellular Ca2+ and acidosis-induced phosphatase inhibition. Our results indicated that PLN was phosphorylated at Thr17 at the onset of reflow and immediately after hypercapnia was established, and that this phosphorylation contributes to the mechanical recovery after both the ischemic and acidic insults. Studies on transgenic mice with Thr17 mutated to Ala (PLN-T17A) are consistent with these results. Thus, phosphorylation of the Thr17 residue of PLN probably participates in a protective mechanism that favors Ca2+ handling and limits intracellular Ca2+ overload in pathological situations. en
dc.format.extent 563-572 es
dc.language en es
dc.subject isoprenaline en
dc.subject β-adrenergic stimulation en
dc.subject acidosis en
dc.subject ischemia en
dc.subject serine en
dc.subject threonine en
dc.subject phospholamban en
dc.subject Thr17 site phosphorylation en
dc.subject hypercapnia en
dc.subject pathophysiology en
dc.subject physiology en
dc.title The importance of the Thr17 residue of phospholamban as a phosphorylation site under physiological and pathological conditions en
dc.type Articulo es
sedici.identifier.uri http://www.scielo.br/pdf/bjmbr/v39n5/6159.pdf es
sedici.identifier.other https://doi.org/10.1590/S0100-879X2006000500001
sedici.identifier.issn 0100-879X es
sedici.creator.person Mattiazzi, Alicia Ramona es
sedici.creator.person Mundiña-Weilenmann, Cecilia es
sedici.creator.person Vittone, Leticia es
sedici.creator.person Said, María Matilde es
sedici.creator.person Kranias, E. G. es
sedici.subject.materias Ciencias Médicas es
sedici.description.fulltext true es
mods.originInfo.place Facultad de Ciencias Médicas es
sedici.subtype Revision es
sedici.rights.license Creative Commons Attribution-NonCommercial 3.0 Unported (CC BY-NC 3.0)
sedici.rights.uri http://creativecommons.org/licenses/by-nc/3.0/
sedici.description.peerReview peer-review es
sedici.relation.journalTitle Brazilian Journal of Medical and Biological Research es
sedici.relation.journalVolumeAndIssue vol. 39, no. 5 es


Descargar archivos

Este ítem aparece en la(s) siguiente(s) colección(ones)

Creative Commons Attribution-NonCommercial 3.0 Unported (CC BY-NC 3.0) Excepto donde se diga explícitamente, este item se publica bajo la siguiente licencia Creative Commons Attribution-NonCommercial 3.0 Unported (CC BY-NC 3.0)